
Meeting Report: Using Stem Cells for Biological and Therapeutics Discovery in Mental Illness, April 2012
Author(s) -
Panchision David M.
Publication year - 2013
Publication title -
stem cells translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.781
H-Index - 71
eISSN - 2157-6580
pISSN - 2157-6564
DOI - 10.5966/sctm.2012-0149
Subject(s) - government (linguistics) , translational research , identification (biology) , brainstorming , induced pluripotent stem cell , mental health , mental illness , general partnership , reprogramming , session (web analytics) , medicine , psychology , computer science , psychiatry , biology , political science , world wide web , pathology , artificial intelligence , philosophy , linguistics , botany , embryonic stem cell , biochemistry , gene , law , genetics , cell
This report synthesizes the discussions during a workshop convened by the National Institute of Mental Health and the Foundation for the NIH that focused on progress and challenges in the use of patient‐derived reprogrammed cells for basic biological discovery, target identification, screening, and drug development for mental illnesses. The meeting revealed that the greatest progress has been made in reprogramming methods and agreed‐upon standards for validating the resulting induced pluripotent stem cell lines and provided an important venue to address potential opportunities for translational and clinical applications of reprogrammed cell research.